Prosecution Insights
Prosecution Insights
1 pending office actions • 0 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Rgenta Therapeutics Inc. currently has 1 pending office action. This action is being reviewed by 1 distinct examiner, NILOOFAR RAHMANI. As the busiest examiner for the portfolio, NILOOFAR RAHMANI is responsible for 1 pending office action, which constitutes the entire pending workload for the company.
The data indicates that there are 0 distinct art units associated with these pending actions. With only 1 pending office action and 1 distinct examiner, the company's current prosecution is highly focused. This suggests that the company's immediate patent office interactions are limited to a single point of contact, NILOOFAR RAHMANI, and a single pending matter.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| RAHMANI, NILOOFAR | 1 | 77.5% | -2.9% |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18711986 | HETEROCYCLIC SUBSTITUTED 1,3,4-THIADIAZOLE AND PYRIDAZINE COMPOUNDS AND METHODS OF USING THE SAME | RAHMANI, NILOOFAR | — | §112 | Non-Final OA | — | Pending | May 21, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial